Cited by 105Gestational Diabetes Research and ManagementPregnancy and Medication ImpactDiabetes Management and Research

Trends in the incidence of diabetes, its clinical sequelae, and associated costs in pregnancy

Open access
Jovanovič, Lois, Liang, Yuanjie, Weng, Wayne, Hamilton, Marianthe, Chen, Lisa, Wintfeld, Neil·2015·Diabetes/Metabolism Research and Reviews

Abstract

BACKGROUND: Increasing diabetes prevalence affects a substantial number of pregnant women in the United States. Our aims were to evaluate health outcomes, medical costs, risks and types of complications associated with diabetes in pregnancy for mothers and newborns. METHODS: In this retrospective claims analysis, patients were identified from the Truven Health MarketScan(®) database (2004-2011 inclusive). Participants were aged 18-45 years, with ascertainable diabetes status [Yes/No], date of birth event >2005 and continuous health plan enrolment ≥21 months before and 3 months after the birth. RESULTS: In total, 839 792 pregnancies were identified, and 66 041 (7.86%) were associated with diabetes mellitus [type 1 (T1DM), 0.13%; type 2 (T2DM), 1.21%; gestational (GDM), 6.29%; and GDM progressing to T2DM (patients without prior diabetes who had a T2DM diagnosis after the birth event), 0.23%]. Relative risk (RR) of stillbirth (2.51), miscarriage (1.28) and Caesarean section (C-section) (1.77) was significantly greater with T2DM versus non-diabetes. Risk of C-section was also significantly greater for other diabetes types [RR 1.92 (T1DM); 1.37 (GDM); 1.63 (GDM progressing to T2DM)]. Risk of overall major congenital (RR ≥ 1.17), major congenital circulatory (RR ≥ 1.19) or major congenital heart (RR ≥ 1.18) complications was greater in newborns of mothers with diabetes versus without. Mothers with T2DM had significantly higher risk (RR ≥ 1.36) of anaemia, depression, hypertension, infection, migraine, or cardiac, obstetrical or respiratory complications than non-diabetes patients. Mean medical costs were higher with all diabetes types, particularly T1DM ($27 531), than non-diabetes ($14 355). CONCLUSIONS: Complications and costs of healthcare were greater with diabetes, highlighting the need to optimize diabetes management in pregnancy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/dmrr.2656

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The ongoing epidemic of obesity and diabetes has led to more type 2 diabetes in people of reproductive age, with an increase in pregnant individuals with undiagnosed type 2 diabetes in early pregnancy.

    “The ongoing epidemic of obesity and diabetes has led to more type 2 diabetes in people of reproductive age, with an increase in the number of pregnant individuals with undiagnosed type 2 diabetes in early pregnancy (179 -181).”

    From 2. Diagnosis and Classification of Diabetes: <i>Standards of Care in Diabetes—2024</i> (2024) · cites this paper as [181]

    The Introduction reports increasing diabetes among women of child-bearing age, and the Results report a modest increase in T2DM among pregnant women since 2005. The Introduction’s estimate of undiagnosed diabetes concerns US adults generally, not pregnant individuals in early pregnancy. The cited passages do not establish that obesity caused the increase or that undiagnosed T2DM increased in early pregnancy. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • The ongoing epidemic of obesity and diabetes has led to more type 2 diabetes in people of reproductive age, with an increase in the number of pregnant individuals with undiagnosed type 2 diabetes in early pregnancy.

    “The ongoing epidemic of obesity and diabetes has led to more type 2 diabetes in people of reproductive age, with an increase in the number of pregnant individuals with undiagnosed type 2 diabetes in early pregnancy (164-166).”

    From 2. Diagnosis and classification of diabetes: standards of care in diabetes-2025 (2025) · cites this paper as [166]

    The Introduction and Results report increasing type 2 diabetes among women of child-bearing age and pregnant women. The Introduction gives an estimate of undiagnosed diabetes only for US adults generally; it does not establish an increase among pregnant people in early pregnancy. The paper also does not attribute the increase to obesity. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Jovanovič, L., Liang, Y., Weng, W., Hamilton, M., Chen, L., & Wintfeld, N.
Affiliations
  • Sansum Diabetes Research Institute Santa Barbara CA USA
  • Novo Nordisk (United States) (US)
Venue
Diabetes/Metabolism Research and Reviews
Publisher
Wiley
Published
2015-06-16
Volume
31
Issue
7
Pages
707-716
ISSN
  • 1520-7552 (ISSN-L)
  • 1520-7560
OpenAlex
W1493539808
Cited by
105
References
26
Citations by year
2026: 4 · 2025: 9 · 2024: 5 · 2023: 8 · 2022: 12 · 2021: 14 · 2020: 20 · 2019: 12 · 2018: 9 · 2017: 5 · 2016: 7
FWCI
7.97
Type
journal article
Language
en
Open access
Locations
  • Diabetes/Metabolism Research and Reviews (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
Novo Nordisk Inc.
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
diabetes in pregnancy, gestational diabetes mellitus, type 1 diabetes, type 2 diabetes, pregnancy complications, stillbirth, miscarriage, cesarean section, congenital malformations, maternal outcomes, health care costs, maternal morbidity
MeSH terms
Congenital Abnormalities, Abortion, Spontaneous, Adolescent, Adult, Anemia, Cesarean Section, Depression, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Female, Heart Defects, Congenital, Humans, Infant, Newborn, Middle Aged, Pregnancy, Pregnancy Complications, Cardiovascular, Pregnancy Complications, Hematologic, Pregnancy Complications, Infectious, Pregnancy in Diabetics, Pregnancy Outcome, Retrospective Studies, United States, Incidence, Diabetes, Gestational, Health Care Costs, Stillbirth, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review